SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives

Marco Lombardi, Andrea Batazzi, Bernardo Martini, Alma Mehmetaj, Stefano Michelassi

Open source

DOI
10.33393/gcnd.2025.3674
Published
December
Container
Giornale di Clinica Nefrologia e Dialisi
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.33393/gcnd.2025.3674,
  title = {SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives},
  author = {Marco Lombardi and Andrea Batazzi and Bernardo Martini and Alma Mehmetaj and Stefano Michelassi},
  year = {2025},
  journal = {Giornale di Clinica Nefrologia e Dialisi},
  doi = {10.33393/gcnd.2025.3674},
  url = {https://doi.org/10.33393/gcnd.2025.3674}
}

RIS

TY  - JOUR
TI  - SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives
AU  - Marco Lombardi
AU  - Andrea Batazzi
AU  - Bernardo Martini
AU  - Alma Mehmetaj
AU  - Stefano Michelassi
PY  - 2025
JO  - Giornale di Clinica Nefrologia e Dialisi
DO  - 10.33393/gcnd.2025.3674
UR  - https://doi.org/10.33393/gcnd.2025.3674
ER  - 

APA

Lombardi, M., Batazzi, A., Martini, B., Mehmetaj, A., & Michelassi, S. (2025). SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives. Giornale di Clinica Nefrologia e Dialisi. https://doi.org/10.33393/gcnd.2025.3674

Source records